1Bartlett JMS, Adie L, Watters AD, et al. Chromosome aberrations in transitional cell carcinoma that predictive of disease outcome are independent of polyploidy. BJU International, 1999 ,84: 775 - 779.
2Bartlett JMS, Watters AD, Ballantyne SA, et al. Is chromosome 9 loss a marker of disease recurrence in transitional cell carcinoma of the urinary bladder?. Br J Cancer, 1998,77(12) :2193 - 2198.
3Edwards J, Duncan P, Going JJ, et al. Identification of loci associated with putative recurrence gene in transitional cell carcinoma of the urinary bladder. J Pathol, 2002,196: 380 - 385.
4Miyao N, Tsai YC, Lerner SP, et al. Role of chromosome 9 in human bladder cancer. Cancer Res, 1993,53:4066- 4070.
5SauterG,MochH,CarrollP,et al. Chromosome-9 loss detected by Fluorescence In Situ Hybridization in bladder cancer. Int J Cancer, 1995,64:99- 103.
6Simon R, Burger H, Brinkschmidt C, Bocker W, et al. Chromosomal aberrations associated with invasion in papillary superficial bladder cancer. J Pathol, 1998,185(4) :345 - 351.
7Simoneau M, LaRue H, Aboulkassim T, et al. Chromosome 9 deletions and recurrence of superficial bladder cancer: identification of four regions of prognostic interest. Oncogene, 2000,19 ( 54 ): 6317 - 6323.
8Jung I, Reeder J, Cox C, et al. Chromosome 9 monosomy by Fluorescence In Situ Hybridization of bladder irrigation specimens is predictive of tumor recurrence. J Urol, 1999,162:1900 - 1903.
9Edwards J, Duncan P, Going JJ, et al. Loss of heterozygosity on chromosome 9 as a potential marker of recurrence and progression in bladder cancer. Br J Cancer, 2000, 83 (Suppl): 76.
10Kimura F, Florl AR, Seffert HH, et al. Destabilization of chromosome 9 in transitional cell carcinoma of the urinary bladder. Br J Cancer, 2001,85(12): 1887 - 1893.
4Kipp BR, Karnes RJ, Brankley SM, et al. Monitoring intravesical therapy for superficial bladder cancer using fluorescence insitu hybridization[J]. J Urol,2005,173:401.
5Gallucci M, Guadagni F, Marzano R, et al. Status of the p53, p16, RB1, and HER-2 genes and chromosomes 3, 7,9, and 17 in advanced bladder cancer: correlation with adjacent mucosa and pathological parameters[J]. J Clin Pathol, 2005,58(4) : 367-371.
6Kruger S, Mess F, Bohle A, et al. Numerical aberrations of chromosome 17 and the 9p21 locus are independent predictors of tumor recurrence in non-invasive transitional cell carcinoma of the urinary bladder[J]. Int J Oncol,2003,23(1) :41-48.
7Mhawech-Fauceglia P, Fischer G, Beck A, et al. Raf1,Aurora-A/STK15 and E-cadherin biomarkers expression in patients with pTa/pT1 urothelial bladder carcinoma: a retrospective TMA study of 246 patients with long-term follow-up [J]. Eur J Surg Oncol,2006,32(4) :439-444.
8Sandberg AA, Berger CS. Review of chromosome studies in urological tumors Ⅱ. Cytogenetics and molecular genetics of bladder cancer[J]. J Urol, 1994, 151(3) :545 - 560.
9Falor WH. Prognosis in earlycareinorna of the bladder based on chromosomal analysis[J]. J Urol, 1978, 119(1) :44- 48.
